DURECT Corp.
(NASDAQ : DRRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.22%38.480.9%$1249.65m
JNJJohnson & Johnson 0.82%148.420.7%$899.85m
MRKMerck & Co., Inc. -0.15%81.550.7%$646.59m
ABBVAbbVie, Inc. -1.08%93.271.9%$600.36m
AZNAstraZeneca Plc -0.27%55.931.2%$581.40m
BMYBristol-Myers Squibb Co. 0.43%59.731.0%$564.86m
LLYEli Lilly & Co. -0.56%153.981.1%$448.26m
NVSNovartis AG -0.65%83.600.2%$138.26m
GSKGlaxoSmithKline Plc -0.04%41.230.2%$135.10m
OPKOPKO Health, Inc. 1.03%5.4211.2%$128.96m
MISTMilestone Pharmaceuticals, Inc. -4.27%8.960.0%$121.67m
RGENRepligen Corp. -0.38%155.957.1%$73.55m
NVONovo Nordisk A/S 0.60%65.020.1%$66.06m
PRNBPrincipia Biopharma, Inc. 2.94%88.200.0%$58.55m
IMRNImmuron Ltd. 8.43%11.190.0%$53.48m

Company Profile

DURECT Corp. is a biopharmaceutical company. It engages in the research, development, and manufacturing of pharmaceutical products. The company products include alzet and lactel. Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.